PharmaSentinel Partners with Pay10 for Medsii.com Expansion
PharmaSentinel Limited has announced a significant license agreement with Pay10 for its flagship product, Medsii.com, announced in a press release. This partnership allows PharmaSentinel to further develop its AI-driven digital health solutions, while enabling Pay10 to enhance its intelligence services.
Medsii.com is a B2B platform that leverages AI to provide comprehensive scientific, clinical, regulatory, and competitive intelligence. This collaboration is expected to help PharmaSentinel capitalize on the growing healthcare analytics market, which is expanding at a 20% CAGR.
The agreement will also allow Pay10 to offer enhanced insights and regulatory support to its global users, driving innovation and improving data accessibility for stakeholders worldwide. Terms of the agreement remain confidential.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Seeq and Cognizant Collaborate on Industrial AI for Drug Manufacturing
Sensydia Raises More Than $6 Million for AI Cardiac System
Medsender Launches Agentic Referral Management for Specialty Practices
SENA Health Raises Series A for AI Care Coordination
Daily AI Brief: the AI news that matters, in your inbox.